Switch theme
Sign up to access all valuation multiples
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
2007
969
LTM Revenue $97.6M
LTM EBITDA $16.6M
$198M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Selvita has a last 12-month revenue (LTM) of $97.6M and a last 12-month EBITDA of $16.6M.
In the most recent fiscal year, Selvita achieved revenue of $90.7M and an EBITDA of $14.7M.
Selvita expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Selvita valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $97.6M | XXX | $90.7M | XXX | XXX | XXX |
| Gross Profit | $97.6M | XXX | $71.0M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 78% | XXX | XXX | XXX |
| EBITDA | $16.6M | XXX | $14.7M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $1.9M | XXX | -$0.1M | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| Net Profit | $0.1M | XXX | -$1.6M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | -2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $25.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Selvita's stock price is PLN 30 (or $8).
Selvita has current market cap of PLN 554M (or $147M), and EV of PLN 747M (or $198M).
See Selvita trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $198M | $147M | XXX | XXX | XXX | XXX | $-0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Selvita has market cap of $147M and EV of $198M.
Selvita's trades at 2.2x EV/Revenue multiple, and 13.5x EV/EBITDA.
Equity research analysts estimate Selvita's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Selvita has a P/E ratio of 2037.0x.
See valuation multiples for Selvita and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $147M | XXX | $147M | XXX | XXX | XXX |
| EV (current) | $198M | XXX | $198M | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 11.9x | XXX | 13.5x | XXX | XXX | XXX |
| EV/EBIT | 104.9x | XXX | -1529.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 2037.0x | XXX | -90.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 16.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSelvita's last 12 month revenue growth is 19%
Selvita's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Selvita's rule of 40 is 55% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Selvita's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Selvita and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 50% | XXX | -21% | XXX | XXX | XXX |
| Rule of 40 | 55% | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 65% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 78% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
| Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
| Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
| Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Selvita acquired XXX companies to date.
Last acquisition by Selvita was XXXXXXXX, XXXXX XXXXX XXXXXX . Selvita acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Selvita founded? | Selvita was founded in 2007. |
| Where is Selvita headquartered? | Selvita is headquartered in Poland. |
| How many employees does Selvita have? | As of today, Selvita has 969 employees. |
| Is Selvita publicy listed? | Yes, Selvita is a public company listed on WAR. |
| What is the stock symbol of Selvita? | Selvita trades under SLV ticker. |
| When did Selvita go public? | Selvita went public in 2019. |
| Who are competitors of Selvita? | Similar companies to Selvita include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
| What is the current market cap of Selvita? | Selvita's current market cap is $147M |
| What is the current revenue of Selvita? | Selvita's last 12 months revenue is $97.6M. |
| What is the current revenue growth of Selvita? | Selvita revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Selvita? | Current revenue multiple of Selvita is 2.0x. |
| Is Selvita profitable? | Yes, Selvita is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Selvita? | Selvita's last 12 months EBITDA is $16.6M. |
| What is Selvita's EBITDA margin? | Selvita's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Selvita? | Current EBITDA multiple of Selvita is 11.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
